Prenetics Global Limited
PRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $31 | $22 | $13 | $13 |
| % Growth | 40.8% | 65.2% | 5% | – |
| Cost of Goods Sold | $15 | $13 | $10 | $9 |
| Gross Profit | $15 | $9 | $4 | $4 |
| % Margin | 50.3% | 40.6% | 27.5% | 28.7% |
| R&D Expenses | $11 | $12 | $6 | $6 |
| G&A Expenses | $47 | $41 | $59 | $48 |
| SG&A Expenses | $55 | $50 | $64 | $54 |
| Sales & Mktg Exp. | $9 | $8 | $5 | $6 |
| Other Operating Expenses | -$3 | -$1 | -$0 | $0 |
| Operating Expenses | $64 | $61 | $70 | $60 |
| Operating Income | -$48 | -$52 | -$66 | -$57 |
| % Margin | -157.2% | -238.7% | -501.5% | -452.1% |
| Other Income/Exp. Net | -$10 | -$5 | -$160 | -$160 |
| Pre-Tax Income | -$58 | -$57 | -$226 | -$217 |
| Tax Expense | -$8 | -$0 | -$0 | $3 |
| Net Income | -$46 | -$63 | -$190 | -$174 |
| % Margin | -151.2% | -288.5% | -1,446.8% | -1,388.4% |
| EPS | -3.64 | -5.58 | -37.57 | -47.04 |
| % Growth | 34.8% | 85.1% | 20.1% | – |
| EPS Diluted | -3.64 | -5.58 | -37.57 | -47.04 |
| Weighted Avg Shares Out | 13 | 11 | 5 | 4 |
| Weighted Avg Shares Out Dil | 13 | 11 | 5 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $4 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $8 | $8 | $7 |
| EBITDA | -$52 | -$48 | -$218 | -$209 |
| % Margin | -168.4% | -220.3% | -1,656.3% | -1,668.9% |